Leading countries in life sciences sector M&As 2019

The United States led the mergers and acquisitions market in the life sciences sector in 2019. Life sciences companies based in the United States made 537 acquisitions, and there were 480 deals involving the purchase of target companies headquartered in the United States. China established itself as the second-largest market for life sciences mergers and acquisitions.

Mergers and acquisitions are shaping the life sciences industry

There were approximately 2,000 global deals announced in the life sciences mergers and acquisitions market in 2019, which was a decrease of 832 deals on the previous year. However, the estimated value of those deals increased from 296 billion U.S. dollars in 2018 to 362 billion U.S. dollars in 2019. Disclosed values were announced for 1,063 mergers and acquisitions, and large-scale transactions continued to dominate the life sciences market – the overall value of the ten largest announced deals was approximately 250 billion U.S. dollars.

What are the life sciences?

Life sciences are the branches of science that deal with the research and study of living organisms, such as animals, plants, and human beings. The sector is composed of companies that focus on core segments, including pharmaceutical products, medical technology, and biotechnology. Companies that develop branded pharmaceuticals are increasingly using mergers and acquisitions as a way of limiting the impact of falling revenues when key patents expire and generics enter the market. AbbVie – the company that manufacturers the blockbuster drug Humira – acquired competitor Allergan for approximately 63 billion U.S. dollars in 2019.

Leading countries in global life sciences mergers and acquisitions based on deal number in 2019*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until June 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

October 2019



Survey time period

as of October 2019

Supplementary notes

Life sciences include: medicinal chemicals and botanical products; pharmaceutical preparations; in-vitro and in-vivo diagnostics; biotechnology, biological products, except diagnostic substances; pharmaceutical wholesale; medical devices and diagnostics; plant sciences.

* Includes M&A deals for Q1-Q3 2019.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "U.S. pharmaceutical industry"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.